QuickLinks -- Click here to rapidly navigate through this document



 

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


SCHEDULE TO
(Amendment No. 3)
(RULE 13e-4)
TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR SECTION 13(e)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934


CELESTICA INC.
(NAME OF SUBJECT COMPANY (ISSUER) AND FILING PERSON)

VARIOUS CLASSES OF OPTIONS TO PURCHASE SUBORDINATE VOTING SHARES
HAVING AN EXERCISE PRICE PER SHARE OF U.S.$30.00 (OR CDN. $40.00) OR GREATER
(TITLE OF CLASS OF SECURITIES)

15101Q108
(CUSIP NUMBER OF SUBORDINATE VOTING SHARES UNDERLYING OPTIONS)

Kaye Scholer LLP
425 Park Avenue
New York, New York
Attention: Managing Attorney's Office
(212) 836-8000
(NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE
NOTICES AND COMMUNICATIONS ON BEHALF OF THE FILING PERSON)


COPIES TO:

Lynn Toby Fisher, Esq.
Joel I. Greenberg, Esq.
Kaye Scholer LLP
425 Park Avenue
New York, New York 10022
(212) 836-8000
  I. Berl Nadler, Esq.
Davies Ward Phillips & Vineberg LLP
1 First Canadian Place, Suite 4400
Toronto, Ontario
Canada M5X 1B1
(416) 863-0900


CALCULATION OF FILING FEE


TRANSACTION VALUATION*

  AMOUNT OF FILING FEE


U.S.$6,962,264   U.S.$819.46

*
Calculated solely for purposes of determining the filing fee. This amount assumes the purchase of all options to purchase subordinate voting shares of Celestica Inc. issued pursuant to stock option plans outstanding on May 31, 2005, with an exercise price of U.S.$30.00 or greater, or Cdn.$40.00 or greater for Canadian dollar-denominated options, for a maximum aggregate purchase price of U.S.$6,962,264.00. The amount of the filing fee is calculated by multiplying the transaction value by 0.00011770.

ý
Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

Amount Previously Paid:   US$819.46   Filing Party:   Celestica Inc.
Form or Registration No.:   Schedule TO   Date Filed:   June 13, 2005
o
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

o
Check the appropriate boxes below to designate any transactions to which the statement relates:

o
third-party tender offer subject to Rule 14d-1.

ý
issuer tender offer subject to Rule 13e-4.

o
going private transaction subject to Rule 13e-3.




o
amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer:    o


        This Amendment No. 3 (this "Amendment") amends and supplements the Tender Offer Statement on Schedule TO originally filed with the Securities and Exchange Commission on June 13, 2005, as amended and supplemented by Amendment No. 1 to the Schedule TO filed with the Securities and Exchange Commission on July 1, 2005 and Amendment No. 2 to the Schedule TO as filed with the Securities and Exchange Commission on July 11, 2005 (the original Schedule TO as so amended, the "Schedule TO") by Celestica Inc., an Ontario, Canada corporation ("Celestica"), relating to an offer by Celestica to its employees, for compensatory purposes, to purchase for cash, from eligible participants, all outstanding options with an exercise price of U.S.$30.00 or greater, or Cdn.$40.00 or greater for Canadian dollar-denominated options, to purchase Celestica's subordinate voting shares issued under Celestica's Long-Term Incentive Plan, as amended, the Second Amended and Restated Non-Qualified Stock Option Plan, as amended, the 2000 Non-Qualified Stock Option Plan and the 2000 Equity Incentive Plan, as amended, on the terms and subject to the conditions set forth in an Offer to Purchase Specified Options (the "Offer Statement"), dated June 13, 2005, and in the related Letter of Transmittal ("Letter of Transmittal"), filed with the original Schedule TO as Exhibits (a)(1)(i) and (a)(1)(iv), respectively.

        This Amendment is being filed in satisfaction of the requirements of Rule 13e-4(c)(4) promulgated under the Securities and Exchange Act of 1934, as amended.

        The information set forth in the Schedule TO and in the Offer Statement is incorporated into this Amendment by reference with respect to all of the applicable items in the Schedule TO, except that such information is hereby amended and supplemented to the extent expressly provided herein.

Items 2, 4 and 6.

        Items 2, 4 and 6 of the Schedule TO, which each incorporate by reference the information contained in Section 5 of the Offer Statement, are hereby amended as follows:

        The following paragraph is hereby added to the end of the section titled "Section 5. Acceptance for Purchase of Options and Payment of Cash Amount" under the caption "The Offer" of the Offer Statement:

        "The offer, including all withdrawal rights, expired at 12:01 A.M., Eastern Time on July 12, 2005. 2,589 eligible Option holders elected to participate in the offer and, pursuant thereto, Celestica accepted Options to purchase an aggregate of 6,822,797 shares of subordinate voting shares, representing approximately 97% of Options eligible to be tendered in the offer. All Options that were properly tendered and not validly withdrawn by Option holders were accepted by Celestica on July 12, 2005. Upon the terms and subject to the conditions of the Offer to Purchase Specified Options, Celestica will promptly pay an aggregate of U.S.$6,822,797 for such properly tendered Options."

1



SIGNATURE

        After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Dated: July 19, 2005

 

 

 
    CELESTICA INC.

 

 

By:

/s/  
IAIN S. KENNEDY      
Iain S. Kennedy
Group Executive, Global Supply Chain
and Information Technology

2



EXHIBIT INDEX

(a)(1)(i)   Offer to Purchase Specified Options, dated June 13, 2005.*

(a)(1)(ii)

 

Form of Cover Letter to Eligible Participants regarding the Offer to Purchase Specified Options.*

(a)(1)(iii)

 

Offer To Purchase Specified Options For Cash — Procedures.*

(a)(1)(iv)

 

Letter of Transmittal.*

(a)(1)(v)

 

Notice of Election to Withdraw Options From Offer to Purchase Specified Options.*

(a)(1)(vi)

 

Form of Letter/E-mail to Rejected Tendering Option Holders.*

(a)(1)(vii)

 

Form of Schedule of Individual Outstanding Options.*

(a)(1)(viii)

 

Form of Tender Offer Reminder.*

(a)(1)(ix)

 

Notice of Extension of Expiration Date of Offer.*

(a)(1)(x)

 

Notice to Holders Regarding Expected Payroll Dates.*

(a)(1)(xi)

 

Schedule of Expected Payroll Dates.*

(a)(2)

 

Not applicable.

(a)(3)

 

Not applicable.

(a)(4)

 

Not applicable.

(a)(5)

 

Not applicable.

(b)

 

Not applicable.

(c)

 

Not applicable.

(d)(1)

 

Celestica Inc. Long-Term Incentive Plan, as amended, incorporated by reference to Exhibit 4.1 of Celestica's Form S-8 filed with the SEC (file number 333-8821) on May 14, 2002.*

(d)(2)

 

Second Amended and Restated Non-Qualified Stock Option Plan, as amended, incorporated by reference to Exhibit 4.1 of Celestica's Form S-8 filed with the SEC (file number 333-113591) on March 15, 2004.*

(d)(3)

 

2000 Non-Qualified Stock Option Plan, incorporated by reference to Exhibit 4.3 of Celestica's Form S-8 filed with the SEC (file number 333-113591) on March 15, 2004.*

i


(d)(4)   2000 Equity Incentive Plan, as amended, incorporated by reference to Exhibit 4.4 of Celestica's Form S-8 filed with the SEC (file number 333-113591) on March 15, 2004.*

(e)

 

Not applicable.

(f)

 

Not applicable.

(g)

 

Not applicable.

(h)

 

Not applicable.

*
Previously filed with Schedule TO

ii




QuickLinks

CALCULATION OF FILING FEE
SIGNATURE
EXHIBIT INDEX


The information that you are accessing on this website may include forward-looking statements related to our future growth, trends in our industry, our financial and operational results and performance that are based on current expectations, forecast and assumptions involving risk and uncertainties that could cause actual outcomes and results to differ materially.


Read the full Cautionary Note here